# Sveinung Hole

> Sveinung Hole is a Series A investor at Sarsia (Bergen) backing Biotechnology and Pharmaceutical. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sarsia](https://shizune.co/investors/profile/sarsia)
- Location: Bergen, Norway
- Total investments: 4
- Last investment: Jan 2024
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sveinung-hole

Sveinung Hole is a Senior Partner at Sarsia. He attended BI Norwegian Business School.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 50% |
| Pharmaceutical | 2 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Seed | 1 | 25% |
| Series C | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Calluna Pharma | Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These include novel therapeutic candidates that fulfill unmet clinical needs across a spectrum of diseases. | $81.4M | Series A | Jan 23, 2024 |  |
| BerGenBio | BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers. | $12.5M | Series C | Feb 05, 2014 |  |
| BerGenBio | BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers. | $8.8M | Series A | Jan 09, 2012 |  |
| BerGenBio | BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers. | $1.3M | Seed | Mar 02, 2011 |  |

4 of 4 investments shown.

## Co-investors
- [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners) — VC Fund, 3 deals together
- [Investinor](https://shizune.co/investors/profile/investinor) — VC Fund, 3 deals together
- [Birk Venture](https://shizune.co/investors/profile/birk-venture) — VC Fund, 1 deal together
- [p53](https://shizune.co/investors/profile/p53) — VC Fund, 1 deal together

## About Sarsia

VC Fund · Bergen, Norway

Sarsia is an early-stage venture capital investor that invest in science-based technology companies. It was founded in 2006 and is located in Bergen, Hordaland.

3 contacts available at Sarsia.

| Name | Title | Profile |
| --- | --- | --- |
| Erlend Skagseth | Managing Partner | https://shizune.co/investors/profile/erlend-skagseth |
| Jon Trygve Berg | Partner | https://shizune.co/investors/profile/jon-trygve-berg |
| Sveinung Hole | Senior Partner | https://shizune.co/investors/profile/sveinung-hole |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Sveinung Hole invest in?

Sveinung Hole invests primarily in Biotechnology and Pharmaceutical startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sveinung Hole last invest?

The most recent investment recorded for Sveinung Hole closed in Jan 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co